All posts by Unrelated Donors - Google News

11Dec/17

St. Jude gene therapy offers hope for infants with ‘bubble boy’ disease – News-Medical.net


News-Medical.net

St. Jude gene therapy offers hope for infants with ‘bubble boy’ disease
News-Medical.net
Currently, transplantation with a tissue-matched sibling donor is the standard treatment for XSCID. More than 80 percent of XSCID patients, including the infants in this study, do not have matched sibling donors. These patients must rely on unrelated

09Dec/17

Gene therapy improves immunity in babies with ‘bubble boy’ disease – Medical Xpress


Medical Xpress

Gene therapy improves immunity in babies with ‘bubble boy’ disease
Medical Xpress
Ewelina Mamcarz, M.D., presents research at the 2017 ASH conference that indicates that the St. Jude XSCID gene therapy has been well tolerated and effective for infants as young as 2 months old. Credit: Peter Barta / St. Jude Children’s Research

and more »

09Dec/17

Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after … – Life Pulse Health

Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after …
Life Pulse Health
For patients receiving cells from an unrelated donor, the rate of mild-to-severe forms of acute GvHD can reach as high as 80 percent, with up to half of patients dying from the most severe forms. “Given the serious threat of graft-versus-host disease

09Dec/17

Immunotherapy drug nearly eliminates severe acute graft-versus … – EurekAlert (press release)


EurekAlert (press release)

Immunotherapy drug nearly eliminates severe acute graft-versus …
EurekAlert (press release)
Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft

and more »

09Dec/17

St. Jude gene therapy improves immunity in babies with ‘bubble boy … – EurekAlert (press release)


EurekAlert (press release)

St. Jude gene therapy improves immunity in babies with ‘bubble boy …
EurekAlert (press release)
Preliminary findings indicate gene therapy pioneered at St. Jude Children’s Research Hospital is safe and effective for babies with a devastating inherited disorder that leaves them with little or no immune protection.

and more »